COVID-19 - The Infection Challenging the World: a commercial preview
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
11–14 MAY 2021
COVID-19 – The Infection
Challenging the World:
a commercial preview
The Annual Scientific Conference hosted by the British quantification of a broad range of
infectious disease pathogens.
Society for Microbial Technology has been the beneficiary The AltoStar platform enables an
advanced ‘sample to result’ CE/IVD-R
of support and sponsorship from a range of relevant automated workflow for RT-PCR testing
with minimal hands-on time. AltoStar
companies. With this year’s event being held virtually assays include HIV, HCV, HBV, HEV, CMV,
EBV, adenovirus, BKV, JCV, HSV, VZV,
over four days, the following commercial colleagues parvovirus, HHV6, a-Herpes, influenza
and SARS CoV-2.
have grasped the opportunity to be associated with The new complementary FlexStar
product range brings a novel approach to
this important series of webinars. syndromic testing, allowing the customer
to define their own multiplex testing
panel. In addition, the well-known and
Alpha Laboratories trusted RealStar infectious disease assay
Throughout the pandemic, Alpha range, which offers a common protocol
Laboratories has been supplying a range and is validated for use on a broad variety
of swabs and transport tubes to help of RT-PCR instrumentation, has been
facilitate testing demands. The company designed to offer users complete
has also provided expertise and supplies confidence in the validity of results.
to support compliant specimen transport. www.altona-diagnostics.com
Once a swab sample has been
collected there are strict guidelines BD Integrated Diagnostic Solutions
regarding how it should be packaged for BD Integrated Diagnostic Solutions (IDS)
transport to the laboratory. This must be provides solutions from collection to
in accordance with UN3373 regulations, The AltoStar platform from Altona Diagnostics. results, to drive impactful outcomes in
which require the use of primary, patient and healthcare worker safety
secondary and tertiary packaging sample packaging components and for through reducing diagnostic errors,
materials to provide a triple layer added convenience the complete sample improving efficiency and integrated
compliant system. transport kits, such as the popular diagnostic stewardship.
Alpha offers an extensive range of RF95-LL1, including absorbent 95-kPa BD IDS focuses on integrated
pouch, security seal and the rigid outer specimen management, microbiology
box with regulatory markings. Additional
specimen bags are also provided
For transporting large numbers of
samples, the Alpha range of UN3373
Medical Sample Carriers is a popular
choice with medical couriers and for
hospital transport.
www.UN3373.co.uk
Altona Diagnostics
Altona Diagnostics is focused on
A complete packaging solution from bringing to market high-quality molecular
Alpha Laboratories. test systems for the detection and The portable BD Veritor Plus system.
WWW.PATHOLOGYINPRACTICE.COM APRIL 2021 27
11–14 MAY 2021
solutions, STI and cervical cancer of the first commercially available
Sharon Forrest, Biomed Online immunocytochemistry tutor, Liverpool
screening, and COVID-19 diagnostic diagnostic tests for SARS-CoV-2, along
solutions. When it comes to strategies with additional critical tests for COVID-19
implemented to contain the spread of patient management.
SARS-CoV-2, the ability to identify The SARS-CoV-2 R-GENE assay is a
infected patients rapidly is crucial. real-time PCR kit for the detection of
BD offers a range of solutions from SARS-CoV-2. The new BIOFIRE
collection to result for coronavirus testing FILMARRAY Respiratory 2.1 Plus Panel
needs, including swabs, tubes and enables rapid and accurate automated
needles for specimen collection, and detection of pathogens behind respiratory
antigen and molecular tests for detection. infections. It tests for 19 viruses including
The BD Veritor Plus system is the SARS-CoV-2, and four bacteria that cause
portable, easy-to-use rapid testing system respiratory tract infections in 45 minutes.
that allows users to provide patients with HER2 fluorescence in situ hybridisation in a case of Individual VIDAS SARS-CoV-2 IgG and
reliable results for SARS-CoV-2, Flu A+B, invasive breast cancer – Biomed Online learning. IgM antibody assays complement the
Group A Strep and RSV in just minutes. company’s PCR solutions.
Furthermore, BD MAX System PCR and workplace practitioners. A wide range Every COVID-19 patient comes with
detection delivers results in two to of topics in pathology-related areas is a unique profile and experiences the
three hours. available and different course disease differently. Patient management
BDdiagnosticsUKI@bd.com combinations can also be selected for means asking the right questions,
qualifications leading to MSc, PG Dip finding the right answers and providing
or PGCert awards. appropriate care on the entire length of
Each course has been tailored the patient pathway.
specifically by healthcare specialists to www.biomerieux.com
suit workforce needs, and each is
delivered online, fully supported by
specialist tutors in small groups of around
10 students. Using password-protected
learning environments, Biomed Online
offers a safe, structured learning
environment where participants will also
be able to share their experience of
Screen for fungal diseases with BioConnections. pathology in practice with colleagues.
Healthcare organisations in partnership
BioConnections with the University of Greenwich manage
COVID-19 infections present a significant the courses.
risk of secondary infection, as seen in Biomed Online tutors over 700
emerging reports of a link between students per annum, with a >90% pass
COVID-19 and fungal co-infections such rate.
as aspergillosis. Fungal co-infections are www.biomedonline.co.uk
a severe threat to patients already
weakened by COVID-19 infection. bioMérieux
These fungal co-infections need to be The COVID-19 pandemic is an ongoing,
identified rapidly for antifungal therapy unprecedented global health challenge. The MALDI Biotyper from Bruker.
to be successful. bioMérieux is proud to be part of the
Invasive fungal infections can be global response, having developed three Bruker
challenging to identify. Bringing fungal As a result of the global SARS-CoV-2
diagnostics in-house can lead to a pandemic, clinical microbiology
significant reduction in result reporting laboratories are facing a significantly
turnaround time. BioConnections is increased workload. On top of the
introducing a range of products to UK requirement to test for the virus itself,
clinical laboratories for the rapid patients who are critically ill with COVID-
detection of various biomarkers used to 19 are susceptible to secondary bacterial
screen for fungal diseases, and, when infections, which may even escalate to
combined with the Merlin Micronaut sepsis.
antifungal susceptibility testing system, Bruker’s MALDI Biotyper can be
enables rapid targeted patient care. implemented with the MBT Sepsityper
More information on these new IVD Kit, enabling reliable species
products is available from BioConnections identification directly from positive blood
through a virtual presentation. cultures in 15–20 minutes.
www.bioconnections.net “The Sepsityper solution has
revolutionised diagnostic microbiology in
Biomed Online our laboratory. With rapid identification
Biomed Online offers a well-established of a blood culture flagging positive,
suite of short courses delivered over we are able to change treatment and
12 weeks for the continuing professional management properly, escalating or
development of biomedical scientists The BIOFIRE FILMARRAY system from bioMérieux. de-escalating as appropriate. Reducing
28 APRIL 2021 WWW.PATHOLOGYINPRACTICE.COM
11–14 MAY 2021
the time to identification means we are the company is well-established in its the serosurveillance study, the results of
able to improve patient outcomes work with international partners to which have informed the UK government’s
dramatically, and the Sepsityper has not distribute a variety of automated strategy to combat the pandemic.
only improved clinical outcomes but laboratory solutions. www.euroimmun.co.uk
diagnostic practice as well,” says Francis One example of this is COPAN’s newly
Yongblah, Laboratory Manager and HSST launched UniVerse, a high-throughput
Clinical Scientist. system capable of de-capping, re-
www.bruker.com capping, pipetting and aliquoting from
primary tube to secondary tube (or deep-
well plates) prior to molecular diagnostic
testing.
As the name suggests, UniVerse offers
a universal response to some of the most
critical challenges faced by today’s clinical
laboratories. Paring perfectly with every
downstream molecular biology platform,
it ensures the safety of operators, Launch Diagnostics supplies high-quality
eliminates human error, provides rigorous diagnostic reagents, instruments and services.
traceability, and increases productivity.
GeneXpert Xpress from Cepheid. A wide variety of assays can be Launch Diagnostics
accommodated including respiratory, Launch Diagnostics has been a supplier
Cepheid gastrointestinal, hospital-acquired of diagnostic innovation for more than
Over a decade ago, Cepheid set the infections, SARS-CoV-2, HPV and STI 30 years, providing strategic solutions
standard for innovation in automated screening. for the microbiology laboratory.
molecular diagnostics — and the sales@dwscientific.co.uk Partnering with world-leading
company has never looked back. www.dwscientific.com/lab-automation manufacturers, Launch supplies high-
The GeneXpert System has been quality diagnostic reagents, instruments
heralded as game-changing by healthcare and services to the health service
leaders across the globe, enabling pathology departments throughout the
institutions of any size, from small medical UK, Ireland and Europe.
clinics to high-volume reference Launch continually aims to introduce
laboratories and hospitals, to access the latest instruments and assays, such
the speed and accuracy of molecular as offering a total portfolio of COVID-19
diagnostics. diagnostics, from molecular to rapid tests,
Cepheid’s growing Xpert test menu plus molecular controls. In addition, the
spans multiple clinical applications company recently launched the Curian
including healthcare-associated infections, from Meridian Bioscience, a fluorescent
sexual health, critical infectious disease, test analyser.
virology and oncology. Immune response to SARS-CoV-2 infection or Liofilchem’s range of antibiotic
www.cepheid.com vaccination; a trio of tests from EUROIMMUN. resistance tests is currently expanding,
with new antibiotics being introduced
Don Whitley Scientific EUROIMMUN UK and new innovative agar and broth
Don Whitley Scientific is best known EUROIMMUN UK supplies the healthcare dilution panels for easy test set-up and
within laboratory circles for its range of industry with medical diagnostic products interpretation.
modified atmosphere workstations and in the principal areas of autoimmunity, www.launchdiagnostics.com
spiral platers. In addition to this legacy, infectious diseases and allergy.
EUROIMMUN UK is the British
subsidiary of the EUROIMMUN group,
a manufacturer of medical laboratory
diagnostic products. EUROIMMUN was
one of the first companies in the world
to offer a comprehensive panel of
SARS-CoV-2 tests, validated for in vitro
diagnostic purposes.
Tests offered by EUROIMMUN include
direct detection methods and highly
accurate indirect detection methods to
assess the immune response following Comprehensive respiratory pathogen
SARS-CoV-2 infection or vaccination. The detection from Luminex.
latest assays developed by the company
are the Anti-SARS-CoV-2 QuantiVac (IgG), Luminex
the SARS-CoV-2 NeutraLISA and the Whatever the testing algorithm required,
SARS-CoV-2 IGRA. Luminex has something to offer.
EUROIMMUN UK has supported public Processing up to 96 samples in under
health bodies in establishing a serology three hours post-extraction, the NxTAG
The UniVerse, now distributed through assay for use in the National Testing Respiratory Pathogen Panel + SARS-CoV-
Don Whitley Scientific. Strategy since March 2020, especially for 2 detects 23 pathogens in a single well
WWW.PATHOLOGYINPRACTICE.COM APRIL 2021 29
11–14 MAY 2021
including SARS-CoV-2. For a more This enables Mast Group to provide
targeted approach to testing with minimal tools to aid in the diagnosis of clinical
hands-on time and results within two disease, from pioneering antibiotic
hours, then ARIES may be better suited. susceptibility testing to novel molecular
In addition to the ARIES SARS-CoV-2 solutions, Mast Group continues to
assay, Luminex offers many other tests. develop products for the ever-changing Selective enrichment broth and swab from MWE.
Additionally, you can run laboratory- IVD market, creating solutions to support
developed tests with the help of Exo+ clinical diagnosis today and into the treatment for, group B Streptococcus
Ready Mix and Extraction Cassettes future. (GBS) to ensure the best outcome both
Luminex is about to launch its www.mast-group.com for mothers and babies.
combined ARIES SARS-CoV-2, Flu A/B The RCOG recommendation states that
and RSV assay, which simultaneously a gold-standard Enriched Culture Medium
detects these important respiratory swab test should be used as it is proven
pathogens in a simplified sample-to- that, without using a selective enrichment
result format. broth, up to 50% of women who are GBS-
The latest addition to the COVID-19 positive have false-negative culture results.
testing line-up detects 20 viral Prevention of early-onset GBS
pathogens, including SARS-CoV-2, and infections would benefit from improved
three bacterial pathogens in a single detection methods by optimising
well. Using the proven NxTAG and specimen collection and processing
MAGPIX technology, it is possible to procedures. MWE developed Sigma GBS,
process up to 96 extracted nucleic acid a selective enrichment broth, complete
samples in under three hours, with just with swab, designed for isolation of GBS
one pipetting step. from pregnant women, to tackle the issue
www.luminexcorp.com of false negatives, offering patients
accurate results, saving lives and
Mast Group improving outcomes.
Mast Group is a UK-based independent Molecular diagnostics from Mobidiag. www.mwe.co.uk
European manufacturer and supplier of
clinical diagnostic products. Established in Mobidiag National Collection of Type Cultures
Liverpool in 1957, Mast Group has grown Mobidiag develops and markets The National Collection of Type Cultures
into a multinational company exporting molecular diagnostics for gastrointestinal (NCTC) is one of four Culture Collections
globally. The corporate headquarters are infections, antimicrobial resistance operated by Public Health England. NCTC
based in Bootle and Mast has subsidiary management, healthcare-associated is the longest-established collection of its
companies in Reinfeld (Mast Diagnostica) infections and respiratory infections type and entered its centenary year in
and Amiens, France (Mast Diagnostic). (including COVID-19). The company aims 2020. The collection holds over 6000 type
Mast Group were among the first to provide a global solution to clinicians, and reference bacterial strains of medical,
companies to commercialise the antibiotic suited for their own laboratory needs and scientific and veterinary importance.
disc, and continues to work with major capacities. The strains support academic, health,
pharmaceutical companies worldwide in Following the COVID-19 crisis, food and veterinary institutions and are
the development of new products. Mobidiag has harnessed its existing used in microbiology laboratories and
Mast Group focuses on the technologies and expertise to develop research institutes worldwide. All strains
susceptibility, identification and resistance and supply coronavirus molecular are available in a freeze-dried format
along with offering molecular and diagnostic tests. In addition to targeted and DNA from over 100 strains is also
immunochemistry solutions for the IVD tests for COVID-19, it is now offering available.
market. This is achieved through the RESP-4 multiplex panels, which are highly In 2020, NCTC accessioned over 175
investment in personnel, R&D and relevant to both the traditional influenza new strains into the collection from all
infrastructure, including state-of-the-art season and COVID-19. over world. These included 79 newly
manufacturing facilities on Merseyside. Symptoms caused by most common described type strains, strains of recently
winter season viruses (SARS-CoV-2, described taxa, novel bacteriophage,
Influenza A, Influenza B and RSV) can be control strains and recently circulating
very similar, and it is imperative that clinical strains. NCTC is a unique resource
healthcare professionals are able to
distinguish between them rapidly, in order
to start the appropriate treatment.
Amplidiag RESP-4 (for batch testing) and
Microrao .commons.wikimedia.org CC BY-SA 4.0
Novodiag RESP-4 (for on-demand testing)
are now available.
www.mobidiag.com
MWE
Recently, Nadine Dorries, Minister of State
for Mental Health, Suicide Prevention and
Patient Safety, reinforced the importance
of following the Royal College of
Antimicrobial resistance detection Obstetricians and Gynaecologists (RCOG) The National Collection of Type Cultures collection
expertise from Mast Group. guidelines on the prevention of, and holds over 6000 type and reference bacterial strains.
30 APRIL 2021 WWW.PATHOLOGYINPRACTICE.COM
11–14 MAY 2021
and its remit over the past 100 years has Developing the gold standard in
remained largely unchanged: to provide testing, Randox patented Biochip
a trustworthy source of authentic bacterial Technology presents unique testing
strains for use in scientific studies. capabilities by enabling a multiplex
www.phe-culturecollections.org.uk/NCTC testing method. This has found
application in hospitals, clinical research
and molecular laboratories, food testing,
forensic toxicology, veterinary laboratories
and POCT.
Randox adapts quickly to meet market The EntericBio workstation from Serosep UK.
demands and currently offers a diverse
range of testing solutions for COVID-19. RSV with the same easy-to-use freeze-
Utilising its Biochip Technology capable of dried reagents – just add extract.
conducting multiple tests simultaneously, Users who wish to add to their
the Randox Biochip has two tests for diagnostic armoury can do so with assays
COVID-19, one specific and one for STI and fungal testing using SpeeDx
confirmatory, both run on the all-in-one and PathoNostics, both available from
An update and new venture from molecular solution, Vivalytic, a universal, Serosep UK.
Pro-Lab Diagnostics. fully automated, cartridge-based www.serosep.com
platform.
Pro-Lab Diagnostics marketing@randox.com Werfen
Pro-Lab Diagnostics is pleased to www.randox.com Increasing diversity of SARS-CoV-2
continue its support of BSMT. It will be variants and potential higher infectivity
strange not being able to actually meet of new viral strains underline the need to
with our friends and colleagues during identify and track mutations across the
these unprecedented times during the complete viral genome.
pandemic. The Novatec/Gold Standard
The company will provide an update Diagnostics (GSD) Group has launched
on its core products and work over the an innovative molecular solution for the
past year with COVID testing, RT-PCR, identification of the B.1.1.7 (UK) and
lateral-flow, biobanking, racking and B.1.351 (South Africa) variants with a short
benchtop equipment; it has been a busy turnaround time.
year for us all, set to continue as we roll GSD NovaType SARS-CoV-2 Detect
out the new variant kits. & ID is a real-time RT-PCR test for the
Also to be announced is a new venture Comprehensive product range from qualitative detection of SARS-CoV-2, and
into the sepsis point-of-care (POC) testing R-Biopharm Rhône. the subsequent identification of variants.
arena with some newly developed The GSD NovaType SARS-CoV-2 ID
technology. R-Biopharm Rhône is intended as a confirmatory test for
www.pro-lab.co.uk R-Biopharm Rhône is a daughter company potential mutants and should be
of R-Biopharm-AG with over 30 years’ performed on samples positive for
Randox Laboratories experience as a diagnostics developer SARS-CoV-2 using the GSD NovaPrime
Randox, a global healthcare diagnostics and manufacturer. SARS-CoV-2 (COVID-19) real-time PCR kit.
company, is committed to developing With RIDA QUICK, RIDA SCREEN and Further information is available from
state-of-the-art technology including RIDA GENE, the company offers a variety Werfen.
chemistry, immunoassay, molecular and of product technologies including rapid sales.uk@werfen.com
POC platforms, in addition to complete tests for pathogen detection, ELISAs and www.werfen.co.uk
quality control solutions and high-quality PCR assays covering respiratory, enteric,
first- and third-party reagents. STI, transplant and microbiome targets.
All assays are CE/IVD-marked.
In addition to an already extensive
range, the company offers the Microbix
range of Quality Assessment Products
CDC/Cynthia S Goldsmith, A Tamin
(QAPs) to complement diagnostic assays.
www.r-biopharm.com
Serosep UK
Join the growing number of EntericBio
users in the UK, delivering fast and
accurate enteric screening using Serosep Molecular solutions to detect new SARS-CoV-2
UK’s Enteric PCR solution. Test for variants as they emerge are available from
bacteria, parasites and viruses using the Werfen, the exclusive distributor for Novatec
same easy process with freeze-dried (GSD Group) in the UK.
reagents for up to 46 samples per run.
What's new for 2021 from Serosep UK?
For more information, visit the BSMT
Cover the new normal winter screen with website (www.bsmt.org.uk) or email
Vivalytic, the universal, fully automated, RespiBio SARS-CoV-2 and combined Valerie Bevan (vbevan@bsmt.org.uk).
cartridge-based platform from Randox. RespiBio SARS-CoV-2, Flu A, Flu B and
WWW.PATHOLOGYINPRACTICE.COM APRIL 2021 31
You can also read
